Evidence map›Paper›PMID 21814463›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2011

Effect of gene environment interactions on lung function and cardiovascular disease in COPD.

Tillie-Louise Hackett, Dorota Stefanowicz, Farzian Aminuddin, Don D Sin, John E Connett, Nicholas R Anthonisen, Peter D Paré, Andrew J Sandford

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Updates on the COPD gene list.International journal of chronic obstructive pulmonary disease · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Tillie-Louise HackettUniversity of British Columbia, James Hogg Research Laboratories, St Paul's Hospital, Division of Respirology, Department of Medicine, Vancouver, BC, Canada.
Dorota Stefanowicz
Farzian Aminuddin
Don D Sin
John E Connett
Nicholas R Anthonisen
Peter D Paré
Andrew J Sandford
University of British Columbia · CAUniversity of Manitoba · CAUniversity of Minnesota · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundThe objective of this study was to determine if gene-environment interactions between cigarette smoking and interleukin-6 (IL6), interferon-γ (IFNG), interleukin-1β (IL1B), or interleukin-1 receptor antagonist (IL1RN) single nucleotide polymorphisms are associated with lung function decline and cardiovascular disease in chronic obstructive pulmonary disease (COPD).

methodsSingle nucleotide polymorphisms (SNPs) in IL6, IFNG, IL1B, and IL1RN were genotyped in the Lung Health Study and correlated with rate of decline of forced expiratory volume in 1 second (FEV(1)) over 5 years, baseline FEV(1), serum protein levels, cardiovascular disease, and interactions with smoking.

resultsThe IL6 rs2069825 single nucleotide polymorphism was associated with the rate of decline of prebronchodilator FEV(1) (P = 0.049), and was found to have a significant interaction (P = 0.004) with mean number of cigarettes smoked per day. There was also a significant interaction of IFNG rs2069727 with smoking on prebronchodilator (P = 0.008) and postbronchodilator (P =0.01) FEV(1.) The IL6 polymorphism was also associated with cardiovascular disease in heterozygous individuals (P = 0.044), and was found to have a significant interaction with smoking (P = 0.024). None of the genetic variants were associated with their respective serum protein levels.

conclusionThe results suggest interactions of IL6 rs2069825 and IFNG rs2069727 single nucleotide polymorphisms with cigarette smoking on measures of lung function. The IL6 rs2069825 single nucleotide polymorphism also interacted with smoking to affect the risk of cardiovascular disease in COPD patients.

Indexed as

Gene-Environment InteractionPolymorphism, Single NucleotideAdultCanadaCardiovascular DiseasesFemaleForced Expiratory VolumeGene FrequencyGenetic Predisposition to DiseaseHumansInterferon-gammaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinInterleukin-6Linear ModelsLinkage DisequilibriumIL1RN protein, humanIL6 protein, humanInterferon-gammaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinInterleukin-6cardiovascular diseasechronic obstructive pulmonary diseaseforced expiratory volume in one secondgene-environment interactionsinterleukin-6

Identifiers

PMID21814463
PMCPMC3144847
OpenAlexW2148764218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.